# Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery

Study · id `cardio:ct-nct03574311` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03574311](<https://clinicaltrials.gov/study/NCT03574311>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03574311

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.

## Technical summary

Registry record NCT03574311. Randomized; triple masking; primary purpose prevention. Start 2018-10-02 (actual); primary completion 2022-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 210 participants (planned count; ClinicalTrials.gov record NCT03574311, source copy `cardio:ctgov-nct03574311-2021-04-20`, retrieved 2026-10-26)
- Started: 2018-10-02 (actual) (ClinicalTrials.gov record NCT03574311, source copy `cardio:ctgov-nct03574311-2021-04-20`, retrieved 2026-10-26)
- Primary completion: 2022-12 (anticipated) (ClinicalTrials.gov record NCT03574311, source copy `cardio:ctgov-nct03574311-2021-04-20`, retrieved 2026-10-26)
- Completion: 2023-12 (anticipated) (ClinicalTrials.gov record NCT03574311, source copy `cardio:ctgov-nct03574311-2021-04-20`, retrieved 2026-10-26)
- Countries: Finland (ClinicalTrials.gov record NCT03574311, source copy `cardio:ctgov-nct03574311-2021-04-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03574311-2021-04-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery
- Acronym: PREFER-CABG
- Condition: Coronary Artery Disease
- Condition: Postoperative Complications
- Condition: Aortic Valve Stenosis
- Condition: Mitral Valve Disease
- Condition: Aortic Aneurysm, Thoracic
- Intervention (Drug): Ferric carboxymaltose
- Intervention (Other): Physiological saline
- Lead sponsor: Turku University Hospital
- Lead sponsor class: OTHER\_GOV
- Collaborator: Vifor Pharma
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry intervention name matches this record: Ferric carboxymaltose (`core:ferric-carboxymaltose`)
- Registry lists this organization as the lead sponsor: Turku University Hospital (`cardio:org-turku-university-hospital`)

## Provenance

Content hash: fcda3621ae0c12c2feaf270f9faac9fd8501692f4c06a052913abc92f0454b6a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
